Cargando…

NURR1 Is Differentially Expressed in Breast Cancer According to Patient Racial Identity and Tumor Subtype

Breast carcinoma (BCa) remains the second most common cause of cancer-related death among American women. Whereas estrogen receptor (ER) expression is typically regarded as a favorable prognostic indicator, a significant proportion of ER(+) patients still experience either de novo or acquired endocr...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaik, Shahensha, Campbell, Ha’reanna, Williams, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256227/
https://www.ncbi.nlm.nih.gov/pubmed/37304463
http://dx.doi.org/10.3390/biomedinformatics2040045
_version_ 1785057058087763968
author Shaik, Shahensha
Campbell, Ha’reanna
Williams, Christopher
author_facet Shaik, Shahensha
Campbell, Ha’reanna
Williams, Christopher
author_sort Shaik, Shahensha
collection PubMed
description Breast carcinoma (BCa) remains the second most common cause of cancer-related death among American women. Whereas estrogen receptor (ER) expression is typically regarded as a favorable prognostic indicator, a significant proportion of ER(+) patients still experience either de novo or acquired endocrine resistance. Previously, we have shown that the loss of orphan nuclear receptor NURR1 expression is associated with neoplastic transformation of the breast epithelium and shorter relapse-free survival (RFS) among systemically treated breast cancer (BCa) patients. Here, we further ascertain the prognostic value of NURR1 in BCa, and its differential expression among Black and White female BCa patients. We assessed the expression of NURR1 mRNA in BCa patients using the Cancer Genome Atlas (TGCA) and compared the occurrence of basal-like cancer and luminal A breast cancer subtypes. Expression levels were further stratified according to racial identity of the patient. We next assessed the correlation of NURR1 expression with Oncotype DX prognostic markers, and the association of NURR1 expression with relapse free survival in patients treated with endocrine therapy. Our study shows that NURR1 mRNA expression is differentially correlated with luminal A vs. basal-like cancer BCa and is predictive of poor relapse-free survival, confirming a similar trend observed in our previous studies using microarray data. NURR1 expression was positively correlated with expression of Oncotype DX biomarkers associated with estrogen responsiveness, while being inversely correlated with biomarkers associated with cell proliferation. Furthermore, we observed that NURR1 expression was positively associated with greater relapse-free survival at 5 years among patients treated with endocrine therapy. Interestingly, we found that among Black women with luminal A BCa, NURR1 expression was repressed in comparison to White women with the same subtype.
format Online
Article
Text
id pubmed-10256227
institution National Center for Biotechnology Information
language English
publishDate 2022
record_format MEDLINE/PubMed
spelling pubmed-102562272023-06-09 NURR1 Is Differentially Expressed in Breast Cancer According to Patient Racial Identity and Tumor Subtype Shaik, Shahensha Campbell, Ha’reanna Williams, Christopher BioMedInformatics Article Breast carcinoma (BCa) remains the second most common cause of cancer-related death among American women. Whereas estrogen receptor (ER) expression is typically regarded as a favorable prognostic indicator, a significant proportion of ER(+) patients still experience either de novo or acquired endocrine resistance. Previously, we have shown that the loss of orphan nuclear receptor NURR1 expression is associated with neoplastic transformation of the breast epithelium and shorter relapse-free survival (RFS) among systemically treated breast cancer (BCa) patients. Here, we further ascertain the prognostic value of NURR1 in BCa, and its differential expression among Black and White female BCa patients. We assessed the expression of NURR1 mRNA in BCa patients using the Cancer Genome Atlas (TGCA) and compared the occurrence of basal-like cancer and luminal A breast cancer subtypes. Expression levels were further stratified according to racial identity of the patient. We next assessed the correlation of NURR1 expression with Oncotype DX prognostic markers, and the association of NURR1 expression with relapse free survival in patients treated with endocrine therapy. Our study shows that NURR1 mRNA expression is differentially correlated with luminal A vs. basal-like cancer BCa and is predictive of poor relapse-free survival, confirming a similar trend observed in our previous studies using microarray data. NURR1 expression was positively correlated with expression of Oncotype DX biomarkers associated with estrogen responsiveness, while being inversely correlated with biomarkers associated with cell proliferation. Furthermore, we observed that NURR1 expression was positively associated with greater relapse-free survival at 5 years among patients treated with endocrine therapy. Interestingly, we found that among Black women with luminal A BCa, NURR1 expression was repressed in comparison to White women with the same subtype. 2022-12 2022-12-07 /pmc/articles/PMC10256227/ /pubmed/37304463 http://dx.doi.org/10.3390/biomedinformatics2040045 Text en https://creativecommons.org/licenses/by/4.0/This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Shaik, Shahensha
Campbell, Ha’reanna
Williams, Christopher
NURR1 Is Differentially Expressed in Breast Cancer According to Patient Racial Identity and Tumor Subtype
title NURR1 Is Differentially Expressed in Breast Cancer According to Patient Racial Identity and Tumor Subtype
title_full NURR1 Is Differentially Expressed in Breast Cancer According to Patient Racial Identity and Tumor Subtype
title_fullStr NURR1 Is Differentially Expressed in Breast Cancer According to Patient Racial Identity and Tumor Subtype
title_full_unstemmed NURR1 Is Differentially Expressed in Breast Cancer According to Patient Racial Identity and Tumor Subtype
title_short NURR1 Is Differentially Expressed in Breast Cancer According to Patient Racial Identity and Tumor Subtype
title_sort nurr1 is differentially expressed in breast cancer according to patient racial identity and tumor subtype
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256227/
https://www.ncbi.nlm.nih.gov/pubmed/37304463
http://dx.doi.org/10.3390/biomedinformatics2040045
work_keys_str_mv AT shaikshahensha nurr1isdifferentiallyexpressedinbreastcanceraccordingtopatientracialidentityandtumorsubtype
AT campbellhareanna nurr1isdifferentiallyexpressedinbreastcanceraccordingtopatientracialidentityandtumorsubtype
AT williamschristopher nurr1isdifferentiallyexpressedinbreastcanceraccordingtopatientracialidentityandtumorsubtype